Detalhe da pesquisa
1.
Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer.
Clin Adv Hematol Oncol
; 21(11): 572-583, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948593
2.
Surgical resection criteria and neoadjuvant therapies for intrahepatic cholangiocarcinoma.
Clin Adv Hematol Oncol
; 21(11): 584-591, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948594
3.
Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early-Onset Colorectal Cancer.
Oncologist
; 26(10): e1730-e1741, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288237
4.
Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets-PART 1: Biologic Therapies Targeting the Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor.
Oncology (Williston Park)
; 31(7): 539-48, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712098
5.
Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets-PART 2: Approaches Beyond First-Line Therapy, and Novel Biologic Agents Under Investigation.
Oncology (Williston Park)
; 31(7): 573-80, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28712102
6.
TKIs beyond immunotherapy predict improved survival in advanced HCC.
J Cancer Res Clin Oncol
; 149(6): 2559-2574, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35773429
7.
The Role of Immunotherapy in Pancreatic Cancer.
Curr Oncol
; 29(10): 6864-6892, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36290818
8.
The current state of molecular profiling in gastrointestinal malignancies.
Biol Direct
; 17(1): 15, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668531
9.
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Cancer Med
; 11(22): 4169-4181, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499204
10.
A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
J Pancreat Cancer
; 5(1): 12-21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31065624
11.
Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment.
Cancer Chemother Pharmacol
; 80(5): 945-954, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28932966
12.
Pancreatic cancer, treatment options, and GI-4000.
Hum Vaccin Immunother
; 11(4): 931-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933185
13.
Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.
Curr Cancer Drug Targets
; 14(9): 775-93, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25435079
14.
Pancreatic cancer, treatment options, and GI-4000.
Hum Vaccin Immunother
; 10(11): 3347-53, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25585100
15.
Future of targeted agents in metastatic colorectal cancer.
Colorectal Cancer
; 1(5)2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273599
16.
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.
Cancer Chemother Pharmacol
; 70(6): 843-53, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23014737